狂犬病疫苗在犬中的性别差异非特异性效应:一项高死亡率人群随机对照试验的扩展分析
本研究基于一项高死亡率 owned dogs 随机对照试验,分析6周龄首剂狂犬病疫苗及13周龄第二剂对全因死亡的影响,并控制30%失访所致选择偏倚。结果显示首剂疫苗显著增加雌性犬死亡风险(HR 2.69,95%CI 1.27-5.69),对雄性无显著影响;第二剂与雄性死亡风险降低相关(HR 0.33,95%CI 0.10-1.02),对雌性无显著影响。作者认为这些非特异性效应存在性别差异且未受选择偏倚影响。
要点
- 6周龄首剂狂犬病疫苗显著增加雌性犬未来7周全因死亡风险(HR 2.69,95%CI 1.27-5.69)。
- 首剂疫苗对雄性犬全因死亡风险无显著影响(HR 0.91,95%CI 0.32-2.59)。
- 13周龄第二剂与雄性犬死亡风险降低相关(HR 0.33,95%CI 0.10-1.02),对雌性无显著影响。
核心结论
- 在高死亡率犬群中,非活狂犬病疫苗显著影响全因死亡率,且效应被性别强烈修饰。
- 基于因果假设的分析表明,上述结果未受选择偏倚影响。
研究设计与样本
- 研究为一项在高死亡率 owned dogs 中开展的随机对照试验的扩展分析。
- 比较6周龄首剂狂犬病疫苗与13周龄第二剂接种对全因死亡的影响,随访至20周龄。
- 因30%研究对象失访,额外进行控制选择偏倚的分析。
主要发现
- 6周龄首剂接种后7周内,雌性犬全因死亡风险显著增加(HR 2.69,95%CI 1.27-5.69),雄性无显著变化(HR 0.91,95%CI 0.32-2.59)。
- 在存活者中,13周龄第二剂与雄性犬死亡风险降低相关(HR 0.33,95%CI 0.10-1.02),雌性无显著关联(HR 1.64,95%CI 0.59-4.58)。
临床怎么用
- 在制定犬狂犬病免疫程序时,应关注性别可能带来的非特异性死亡风险差异。
- 对雌性犬首剂接种后的短期死亡风险需加强监测与评估。
局限性
- 研究存在30%失访,虽经分析控制选择偏倚,仍可能影响结果解释。
- 结果基于高死亡率犬群,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-live rabies vaccines have been associated with both beneficial and detrimental effects on host population morbidity and mortality rates to unrelated infections in people and animals, and these non-specific effects may differ by sex. Previous animal studies may have been affected by bias, including selection bias due to loss to follow up in randomized controlled trials (RCTs). We previously reported results of an RCT in dogs on the effect of primary rabies vaccine administered at 6 weeks of age on all-cause mortality over a 7-week follow-up period, in a high-mortality population of owned dogs. Here, we report the results from the same trial of a second vaccination at 13 weeks of age, compared to a primary vaccination. Because a relatively high proportion of study subjects (30%) were lost to follow-up in the RCT, we also conducted an analysis to control for possible selection bias over both periods (6 to 13 weeks and 13 to 20 weeks of age). We found that primary rabies vaccination at 6 weeks of age substantially increased the hazard of death from all causes over the next 7 weeks among females (hazard ratio [HR] 2.69, 95% confidence intervals [CI] 1.27-5.69), but not among males (HR 0.91, 95% CI 0.32-2.59). Among survivors, administration of a second dose of rabies vaccine at 13 weeks of age was associated with a decreased hazard of death among males (HR 0.33, 95% CI 0.10-1.02) but not females (HR 1.64, 95% CI 0.59-4.58), when compared to the group receiving their first dose at this age. Based on our causal assumptions, we show that these results were not affected by selection bias. In this high-mortality dog population, receipt of a non-live rabies vaccine substantially affected all-cause mortality rates, with this effect being strongly modified by sex.
引用
- Knobel DL, Arega SM, Conan A, et al. Sex-differential non-specific effects of rabies vaccine in dogs: An extended analysis of a randomized controlled trial in a high-mortality population. Vaccine. 2021. PMID: 33494967. doi:10.1016/j.vaccine.2021.01.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。